Literature DB >> 22278376

Evaluation of a multi-element treatment center for early psychosis in the United States.

Sarah R Uzenoff1, David L Penn, Karen A Graham, Sylvia Saade, Barbara B Smith, Diana O Perkins.   

Abstract

PURPOSE: A growing body of research has demonstrated the potential for comprehensive, phase-specific care to improve clinical and functional outcomes in early psychosis. However, there have been no evaluations of such treatment models in the United States (US). This study is a naturalistic, prospective 1-year follow-up of an early psychosis cohort treated in one of the first US-based multi-element treatment centers.
METHODS: Participants were 163 individuals treated at the Outreach and Support Intervention Services (OASIS) clinic, a multi-element treatment center for early psychosis. Data were collected as part of routine care at 6-month intervals. Primary outcomes included role functioning and involvement in work or school.
RESULTS: Over the course of 1 year of treatment, individuals experienced significant improvements in positive and negative symptoms, role functioning, and global functioning. The proportion of individuals meeting symptom remission and functional remission criteria increased significantly from baseline to 1 year, as did the proportion of individuals attending school. There were also trend-level reductions in substance abuse.
CONCLUSIONS: This study provides preliminary support for the efficacy of comprehensive early intervention services in the US.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22278376     DOI: 10.1007/s00127-011-0467-4

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  33 in total

Review 1.  Psychosocial treatment for first-episode psychosis: a research update.

Authors:  David L Penn; Evan J Waldheter; Diana O Perkins; Kim T Mueser; Jeffrey A Lieberman
Journal:  Am J Psychiatry       Date:  2005-12       Impact factor: 18.112

2.  Testing definitions of symptom remission in first-episode psychosis for prediction of functional outcome at 2 years.

Authors:  Clifford M Cassidy; Ross Norman; Rahul Manchanda; Norbert Schmitz; Ashok Malla
Journal:  Schizophr Bull       Date:  2009-03-25       Impact factor: 9.306

3.  Predictors of remission and recovery in a first-episode schizophrenia spectrum disorder sample: 2-year follow-up of the OPUS trial.

Authors:  Lone Petersen; Anne Thorup; Johan Øqhlenschlaeger; Torben Øqstergaard Christensen; Pia Jeppesen; Gertrud Krarup; Per Jørrgensen; Erik Lykke Mortensen; Merete Nordentoft
Journal:  Can J Psychiatry       Date:  2008-10       Impact factor: 4.356

4.  Remission in first-episode psychosis: predictor variables and symptom improvement patterns.

Authors:  Robin Emsley; Piet P Oosthuizen; Martin Kidd; Liezl Koen; Dana J H Niehaus; H Jadri Turner
Journal:  J Clin Psychiatry       Date:  2006-11       Impact factor: 4.384

5.  A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness.

Authors:  Lone Petersen; Pia Jeppesen; Anne Thorup; Maj-Britt Abel; Johan Øhlenschlaeger; Torben Østergaard Christensen; Gertrud Krarup; Per Jørgensen; Merete Nordentoft
Journal:  BMJ       Date:  2005-09-02

6.  Rapid versus delayed readmission in first-admission psychosis: quality indicators for managed care?

Authors:  T J Craig; S Fennig; M Tanenberg-Karant; E J Bromet
Journal:  Ann Clin Psychiatry       Date:  2000-12       Impact factor: 1.567

7.  Early intervention and recovery for young people with early psychosis: consensus statement.

Authors:  J Bertolote; P McGorry
Journal:  Br J Psychiatry Suppl       Date:  2005-08

8.  Symptom monitoring in the rehabilitation of schizophrenic patients.

Authors:  D Lukoff; R P Liberman; K H Nuechterlein
Journal:  Schizophr Bull       Date:  1986       Impact factor: 9.306

9.  A multi-site Canadian perspective: examining the functional outcome from first-episode psychosis.

Authors:  N M Menezes; A M Malla; R M Norman; S Archie; P Roy; R B Zipursky
Journal:  Acta Psychiatr Scand       Date:  2009-02-05       Impact factor: 6.392

10.  Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison.

Authors:  Joseph P McEvoy; Jeffrey A Lieberman; Diana O Perkins; Robert M Hamer; Hongbin Gu; Arthur Lazarus; Dennis Sweitzer; Christina Olexy; Peter Weiden; Stephen D Strakowski
Journal:  Am J Psychiatry       Date:  2007-07       Impact factor: 18.112

View more
  11 in total

1.  First-Episode Services for Psychotic Disorders in the U.S. Public Sector: A Pragmatic Randomized Controlled Trial.

Authors:  Vinod H Srihari; Cenk Tek; Suat Kucukgoncu; Vivek H Phutane; Nicholas J K Breitborde; Jessica Pollard; Banu Ozkan; John Saksa; Barbara C Walsh; Scott W Woods
Journal:  Psychiatr Serv       Date:  2015-02-02       Impact factor: 3.084

2.  Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program.

Authors:  John M Kane; Delbert G Robinson; Nina R Schooler; Kim T Mueser; David L Penn; Robert A Rosenheck; Jean Addington; Mary F Brunette; Christoph U Correll; Sue E Estroff; Patricia Marcy; James Robinson; Piper S Meyer-Kalos; Jennifer D Gottlieb; Shirley M Glynn; David W Lynde; Ronny Pipes; Benji T Kurian; Alexander L Miller; Susan T Azrin; Amy B Goldstein; Joanne B Severe; Haiqun Lin; Kyaw J Sint; Majnu John; Robert K Heinssen
Journal:  Am J Psychiatry       Date:  2015-10-20       Impact factor: 18.112

3.  Preliminary Evaluation of Washington State's Early Intervention Program for First-Episode Psychosis.

Authors:  Oladunni Oluwoye; Hailey Reneau; Bryony Stokes; Rebecca Daughtry; Elizabeth Venuto; Tenaya Sunbury; Grace Hong; Barbara Lucenko; Bryan Stiles; Sterling M McPherson; Sarah Kopelovich; Maria Monroe-DeVita; Michael G McDonell
Journal:  Psychiatr Serv       Date:  2019-12-18       Impact factor: 3.084

4.  The NAVIGATE Program for First-Episode Psychosis: Rationale, Overview, and Description of Psychosocial Components.

Authors:  Kim T Mueser; David L Penn; Jean Addington; Mary F Brunette; Susan Gingerich; Shirley M Glynn; David W Lynde; Jennifer D Gottlieb; Piper Meyer-Kalos; Susan R McGurk; Corinne Cather; Sylvia Saade; Delbert G Robinson; Nina R Schooler; Robert A Rosenheck; John M Kane
Journal:  Psychiatr Serv       Date:  2015-03-16       Impact factor: 3.084

Review 5.  The History of Coordinated Specialty Care for Early Intervention in Psychosis in the United States: A Review of Effectiveness, Implementation, and Fidelity.

Authors:  Halley Read; Brandon A Kohrt
Journal:  Community Ment Health J       Date:  2021-09-14

6.  Transforming the Treatment of Schizophrenia in the United States: The RAISE Initiative.

Authors:  Lisa B Dixon; Howard H Goldman; Vinod H Srihari; John M Kane
Journal:  Annu Rev Clin Psychol       Date:  2018-01-12       Impact factor: 18.561

7.  The Early Psychosis Intervention Center (EPICENTER): development and six-month outcomes of an American first-episode psychosis clinical service.

Authors:  Nicholas J K Breitborde; Emily K Bell; David Dawley; Cindy Woolverton; Alan Ceaser; Allison C Waters; Spencer C Dawson; Andrew W Bismark; Angelina J Polsinelli; Lisa Bartolomeo; Jessica Simmons; Beth Bernstein; Patricia Harrison-Monroe
Journal:  BMC Psychiatry       Date:  2015-10-28       Impact factor: 3.630

8.  Ten-year audit of clients presenting to a specialised service for young people experiencing or at increased risk for psychosis.

Authors:  Agatha M Conrad; Terry J Lewin; Ketrina A Sly; Ulrich Schall; Sean A Halpin; Mick Hunter; Vaughan J Carr
Journal:  BMC Psychiatry       Date:  2014-11-18       Impact factor: 3.630

Review 9.  Optimizing psychosocial interventions in first-episode psychosis: current perspectives and future directions.

Authors:  Nicholas Jk Breitborde; Aubrey M Moe; Arielle Ered; Lauren M Ellman; Emily K Bell
Journal:  Psychol Res Behav Manag       Date:  2017-04-27

Review 10.  A systematic review of mental health outcome measures for young people aged 12 to 25 years.

Authors:  Benjamin Kwan; Debra J Rickwood
Journal:  BMC Psychiatry       Date:  2015-11-14       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.